188 related articles for article (PubMed ID: 21722352)
1. IL-17 in spondyloarthritis: is the T-party over?
Yeremenko N; Baeten D
Arthritis Res Ther; 2011 Jun; 13(3):115. PubMed ID: 21722352
[TBL] [Abstract][Full Text] [Related]
2. Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response.
Appel H; Maier R; Wu P; Scheer R; Hempfing A; Kayser R; Thiel A; Radbruch A; Loddenkemper C; Sieper J
Arthritis Res Ther; 2011 Jun; 13(3):R95. PubMed ID: 21689402
[TBL] [Abstract][Full Text] [Related]
3. IL-23/IL-17 axis in spondyloarthritis-bench to bedside.
Raychaudhuri SP; Raychaudhuri SK
Clin Rheumatol; 2016 Jun; 35(6):1437-41. PubMed ID: 27075462
[TBL] [Abstract][Full Text] [Related]
4. IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
Baeten D; Adamopoulos IE
Front Immunol; 2020; 11():623874. PubMed ID: 33679714
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
Chen S; Paveley R; Kraal L; Sritharan L; Stevens E; Dedi N; Shock A; Shaw S; Juarez M; Yeremenko N; Baeten D; Payne A
J Autoimmun; 2020 Jul; 111():102435. PubMed ID: 32360069
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17 targeted therapies in axial spondyloarthritis.
Wendling D
Immunotherapy; 2015; 7(11):1125-8. PubMed ID: 26513376
[No Abstract] [Full Text] [Related]
7. New developments in our understanding of ankylosing spondylitis pathogenesis.
Voruganti A; Bowness P
Immunology; 2020 Oct; 161(2):94-102. PubMed ID: 32696457
[TBL] [Abstract][Full Text] [Related]
8. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
Raychaudhuri SK; Saxena A; Raychaudhuri SP
Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
[TBL] [Abstract][Full Text] [Related]
10. A Study of the Immunoregulatory Function of TLR3 and TLR4 on Mesenchymal Stem Cells in Ankylosing Spondylitis.
Li Y; Huang L; Cai Z; Deng W; Wang P; Su H; Wu Y; Shen H
Stem Cells Dev; 2019 Oct; 28(20):1398-1412. PubMed ID: 31456484
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases.
Hammitzsch A; Chen L; de Wit J; Al-Mossawi MH; Ridley A; Sekine T; Simone D; Doig K; Skapenko A; Bowness P
Sci Rep; 2018 Oct; 8(1):15645. PubMed ID: 30353145
[TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders.
Vanaudenaerde BM; Verleden SE; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Geenens R; Van Raemdonck DE; Dupont LJ; Verbeken EK; Meyts I
Am J Respir Crit Care Med; 2011 Apr; 183(8):977-86. PubMed ID: 21097694
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis.
Wendling D; Verhoeven F; Prati C
Expert Opin Biol Ther; 2019 Jan; 19(1):55-64. PubMed ID: 30500270
[TBL] [Abstract][Full Text] [Related]
14. IL-17 Production by γδ
Anipindi VC; Bagri P; Dizzell SE; Jiménez-Saiz R; Jordana M; Snider DP; Stämpfli MR; Kaushic C
Immunohorizons; 2019 Jul; 3(7):317-330. PubMed ID: 31356161
[TBL] [Abstract][Full Text] [Related]
15. Th17 cell responses in spondyloarthritis.
Gaston JSH; Jadon DR
Best Pract Res Clin Rheumatol; 2017 Dec; 31(6):777-796. PubMed ID: 30509440
[TBL] [Abstract][Full Text] [Related]
16. Association between IL-17 and IgA in the joints of patients with inflammatory arthropathies.
Eliçabe RJ; Silva JE; Dave MN; Lacoste MG; Tamashiro H; Blas R; Munarriz A; Rabinovich GA; Di Genaro MS
BMC Immunol; 2017 Feb; 18(1):8. PubMed ID: 28166724
[TBL] [Abstract][Full Text] [Related]
17. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis.
Gracey E; Qaiyum Z; Almaghlouth I; Lawson D; Karki S; Avvaru N; Zhang Z; Yao Y; Ranganathan V; Baglaenko Y; Inman RD
Ann Rheum Dis; 2016 Dec; 75(12):2124-2132. PubMed ID: 27165176
[TBL] [Abstract][Full Text] [Related]
18. Cellular sources of IL-17 in psoriasis: a paradigm shift?
Keijsers RR; Joosten I; van Erp PE; Koenen HJ; van de Kerkhof PC
Exp Dermatol; 2014 Nov; 23(11):799-803. PubMed ID: 25039885
[TBL] [Abstract][Full Text] [Related]
19. The paradoxical role of IL-17 in atherosclerosis.
Gong F; Liu Z; Liu J; Zhou P; Liu Y; Lu X
Cell Immunol; 2015 Sep; 297(1):33-9. PubMed ID: 26077826
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
Martin JC; Baeten DL; Josien R
Clin Immunol; 2014 Sep; 154(1):1-12. PubMed ID: 24858580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
